Posttraumatic brain injury cognitive performance is moderated by variation within ANKK1 and DRD2 Genes

Journal of Head Trauma Rehabilitation

Volumn 30, Issue 6, 2015, Pages E54-E66

  Failla, Michelle D ^a,b   Myrga, John M ^b   Ricker, Joseph H ^d,e   Edward Dixon, C ^a,b   Conley, Yvette P ^c,f,g   Wagner, Amy K ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b University School of Medicine   (United States)

^c School of Public Health   (United States)

^d School of Nursing   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

ANKK1; cognitive deficits; dopamine; DRD2; genetic variation; Rehabilomics; traumatic brain injury

Indexed keywords

ANKYRIN; ANKYRIN REPEAT AND KINASE DOMAIN 1; DOPAMINE 2 RECEPTOR; UNCLASSIFIED DRUG; ANKK1 PROTEIN, HUMAN; DRD2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE;

ADULT; AGED; ARTICLE; ATTENTION; COGNITION; COGNITIVE DEFECT; DEPRESSION; DSM-IV; EXECUTIVE FUNCTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLASGOW COMA SCALE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TRAUMATIC BRAIN INJURY; ADOLESCENT; BRAIN INJURY; COGNITION DISORDERS; COHORT ANALYSIS; GENE EXPRESSION REGULATION; GENETIC VARIATION; GENETICS; PSYCHOLOGY; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN INJURIES; COGNITION DISORDERS; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION; GENETIC VARIATION; GENOTYPE; GLASGOW COMA SCALE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, DOPAMINE D2; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84946707328     PISSN: 08859701     EISSN: 1550509X     Source Type: Journal    
DOI: 10.1097/HTR.0000000000000118     Document Type: Article

References (73)

1. Centers for Disease Control and Prevention. Injury prevention & control: Traumatic brain injury. Traumatic brain injury in the United States: emergency department visits, hospitalizations and deaths 2002-2006. http://www.cdc.gov/traumaticbraininjury/tbi ed.html. Accessed July 28, 2014.
2. Fleming J, Tooth L, Hassell M, Chan W. Prediction of community integration and vocational outcome 2-5 years after traumatic brain injury rehabilitation in Australia. Brain Inj. 1999;13:417-431.
3. Levin H, Benton A, Grossman RG. Neurobehavioral Consequences of Closed Head Injury. New York, NY: Oxford University Press; 1982.
4. Bayley MT, Tate R, Douglas JM, et al. INCOG guidelines for cognitive rehabilitation following traumatic brain injury: methods and overview. J Head Trauma Rehabil. 2014;29:290-306.
5. McAllister TW. Polymorphisms in genes modulating the dopamine system: do they influence outcome and response to medication after traumatic brain injury? J. Head Trauma Rehabil. 2009;24:65-68.
6. Wagner AK. TBI translational rehabilitation research in the 21st century: exploring a Rehabilomics research model. Eur J Phys Rehabil Med. 2010;46:549-556.
7. Wagner AK, Zitelli KTA. Rehabilomics focused perspective on molecular mechanisms underlying neurological injury, complications, and recovery after severe TBI. Pathophysiology. 2013;20(1):39-48. doi:10.1016/j.pathophys.2012.02.007.
8. Braver TS, Cohen JD. On the control of control: The role of dopamine in regulating prefrontal function and working memory. In: Control of Cognitive Processes: Attention and Performance XVIII. Cambridge, MA: MIT Press; 2000;713-737.
9. Aalto S, Br ück A, Laine M, Nagren K, Rinne JO. Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: A positron emission tomography study using the high-Affinity dopamine D2 receptor ligand [11C]FLB 457. J Neurosci. 2005;25:2471-2477.
10. Bales JW, Wagner AK, Kline AE, Dixon CE. Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis. Neurosci Biobehav Rev. 2009;33:981-1003.
11. Shimada R, Abe K, Furutani R, Kibayashi K. Changes in dopamine transporter expression in the midbrain following traumatic brain injury: An immunohistochemical and in situ hybridization study in a mouse model. Neurol Res. 2014;36:239-246.
12. Yan HQ, Kline AE, Ma X, Li Y, Dixon CE. Traumatic brain injury reduces dopamine transporter protein expression in the rat frontal cortex. Neuroreport. 2002;13:1899.
13. Yan HQ, Kline AE, Ma X, Hooghe-Peters EL, Marion DW, Dixon CE. Tyrosine hydroxylase, but not dopamine beta-hydroxylase, is increased in rat frontal cortex after traumatic brain injury. Neuroreport. 2001;12:2323.
14. Wagner AK, Drewencki LL, Chen X, et al. Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury. J Neurochem. 2009;108:986-997.
15. Wagner AK, Chen X, Kline AE, Li Y, Zafonte RD, Dixon CE. Gender and environmental enrichment impact dopamine transporter expression after experimental traumatic brain injury. Exp Neurol. 2005;195:475-483.
16. Wagner AK, Scanlon JM, Becker CR, et al. The influence of genetic variants on striatal dopamine transporter and D2 receptor binding after TBI. J Cereb Blood Flow Metab. 2014;34:1328-1339. doi:10.1038/jcbfm.2014.87.
17. Donnemiller E, Brenneis C, Wissel J, et al. Impaired dopaminergic neurotransmission in patients with traumatic brain injury: A SPET study using 123 I-beta-CIT and 123 I-IBZM. Eur J Nucl Med. 2000;27:1410-1414.
18. Whyte J, Hart T, Vaccaro M, et al. Effects of methylphenidate on attention deficits after traumatic brain injury: A multidimensional, randomized, controlled trial. Am J Phys Med Rehabil. 2004;83: 401-420.
19. Bleiberg J, GarmoeW, Cederquist J, Reeves D. Effect of dexedrine on performance consistency following brain injury: A double-blind placebo crossover case study. Neuropsychiatry Neuropsychol Behav Neurol. 1993;6(4):245-248. http://psycnet.apa.org/psycinfo/1994-22746-001.
20. Wagner AK, Ren D, Conley YP, et al. Sex and genetic associations with cerebrospinal fluid dopamine and metabolite production after severe traumatic brain injury. J Neurosurg. 2007;106: 538-547.
21. McAllister TW, Flashman LA, Harker Rhodes C, et al. Single nucleotide polymorphisms in ANKK1 and the dopamine D2 receptor gene affect cognitive outcome shortly after traumatic brain injury: A replication and extension study. Brain Inj. 2008;22: 705-714.
22. Willmott C, Withiel T, Ponsford J, Burke R. COMT Val158Met and cognitive and functional outcomes after traumatic brain injury. J Neurotrauma. 2014;31(17):1507-1514. doi:10.1089/neu.2013.3308.
23. Lipsky RH, Sparling MB, Ryan LM, et al. Association of COMT Val158Met genotype with executive functioning following traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2005;17:465-471.
24. Willmott C, Ponsford J, McAllister TW, Burke R. Effect of COMT Val158Met genotype on attention and response to methylphenidate following traumatic brain injury. Brain Inj. 2013;27:1281-1286.
25. Ponce G, Pérez-González R, Aragü és M, et al. The ANKK1 kinase gene and psychiatric disorders. Neurotox Res. 2009;16:50-59.
26. McAllister TW, Rhodes CH, Flashman LA, et al. Effect of the dopamine D2 receptor T allele on response latency after mild traumatic brain injury. Am J Psychiatry. 2005;162:1749-1751.
27. Thompson J, Thomas N, Singleton A, et al. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics. 1997;7:479-484.
28. Laakso A, Pohjalainen T, Bergman J, et al. The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-Amino acid decarboxylase in healthy subjects. Pharmacogenet Genomics. 2005;15:387-391.
29. Duan J, Wainwright MS, Comeron JM, et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet. 2003;12:205-216.
30. Udekwu P, Kromhout-Schiro S, Vaslef S, Baker C, Oller D. Glasgow Coma Scale score, mortality, and functional outcome in headinjured patients. J Trauma. 2004;56:1084-1089.
31. Cifu DX, Keyser-Marcus L, Lopez E, et al. Acute predictors of successful return to work 1 year after traumatic brain injury: A multicenter analysis. Arch Phys Med Rehabil. 1997;78: 125-131.
32. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21: 263-265.
33. Comings DE, MacMurray JP. Molecular heterosis: A review. Mol GenetMetab. 2000;71:19-31.
34. Freedman ML, Reich D, Penney KL, et al. Assessing the impact of population stratification on genetic association studies. Nat Genet. 2004;36:388-393.
35. Goldman D, Brown GL, Albaugh B, et al. DRD2 dopamine receptor genotype, linkage disequilibrium, and alcoholism in American Indians and other populations. Alcohol Clin Exp Res. 1993;17: 199-204.
36. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1:480-484.
37. Dodds TA, Martin DP, Stolov WC, Deyo RA. A validation of the functional independence measurement and its performance among rehabilitation inpatients. Arch Phys Med Rehabil. 1993;74:531-536.
38. Reitan R, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. South Tucson, AZ: Neuropsychology Press; 1985.
39. Larrabee GJ, Curtiss G. Construct validity of various verbal and visual memory tests. J Clin Exp Neuropsychol. 1995;17: 536-547.
40. Osterrieth P. The complex figure copy test. Arch Psychol. 1944;30:206-356.
41. Delis DC, Kramer JH, Kaplan E, Ober BA. The California Verbal Learning Test. San Antonio, TX: The Psychological Corporation; 2000.
42. Borkowski J, Benton A, Spreen O. Word fluency and brain damage. Neuropsychologia. 1967;5:135-140.
43. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol Exp Psychol. 1935;18:643-662.
44. Hart T, Whyte J, Kim J, Vaccaro M. Executive function and self-Awareness of "real-world" behavior and attention deficits following traumatic brain injury. J Head Trauma Rehabil. 2005;20: 333-347.
45. Hartikainen KM, Waljas M, Isoviita T, et al. Persistent symptoms in mild to moderate traumatic brain injury associated with executive dysfunction. J Clin Exp Neuropsychol. 2010;32:767-774.
46. Wagner AK, Brett CA, McCullough EH, et al. Persistent hypogonadism influences estradiol synthesis, cognition and outcome in males after severe TBI. Brain Inj. 2012;26(10):1226-1242. doi:10.3109/02699052.2012.667594.
47. Van Veelen NMJ, Grootens KP, Peuskens J, et al. Short-Term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia. Schizophr Res. 2010;120:191-198.
48. Dawson JD, Uc EY, Anderson SW, Johnson AM, Rizzo M. Neuropsychological predictors of driving errors in older adults. J Am Geriatr Soc. 2010;58:1090-1096.
49. Green RE, Colella B, Christensen B, et al. Examining moderators of cognitive recovery trajectories aftermoderate to severe traumatic brain injury. Arch Phys Med Rehabil. 2008;89:S16-S24.
50. Cook KF, Bombardier CH, Bamer AM, Choi SW, Kroenke K, Fann JR. Do somatic and cognitive symptoms of traumatic brain injury confound depression screening? Arch Phys Med Rehabil. 2011;92:818-823.
51. Fann JR, Bombardier CH, Dikmen S, et al. Validity of the Patient Health Questionnaire-9 in assessing depression following traumatic brain injury. J Head Trauma Rehabil. 2005;20:501-511.
52. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57:289-300.
53. Zhang Y, Bertolino A, Fazio L, et al. Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci U S A. 2007;104:20552-20557.
54. Neville MJ, Johnstone EC, Walton RT. Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. HumMutat. 2004;23:540-545.
55. Cools R, DEsposito M. Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry. 2011;69:e113-e125.
56. Munafo MR, Matheson IJ, Flint J. Association of the DRD2 gene Taq1A polymorphism and alcoholism: A meta-Analysis of case-control studies and evidence of publication bias. Mol Psychiatry. 2007;12:454-461.
57. Zawarynski P, Tallerico T, Seeman P, Lee SP, ODowd BF, George SR. Dopamine D2 receptor dimers in human and rat brain. FEBS Lett. 1998;441:383-386.
58. Laine TP, Ahonen A, Räsänen P, Pohjalainen T, Tiihonen J, Hietala J. The A1 allele of the D2 dopamine receptor gene is associated with high dopamine transporter density in detoxified alcoholics. Alcohol Alcohol. 2001;36:262-265.
59. Lee FJ, Pei L, Moszczynska A, Vukusic B, Fletcher PJ, Liu F. Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. EMBO J. 2007;26:2127-2136.
60. Hoofien D, Vakil E, Gilboa A, Donovick PJ, Barak O. Comparison of the predictive power of socio-economic variables, severity of injury and age on long-Term outcome of traumatic brain injury: sample-specific variables versus factors as predictors. Brain Inj. 2002;16:9-27.
61. León-Carrión J, Machuca-Murga F, Soĺis-Marcos I, León-Domínguez U, Domínguez-Morales MDR. The sooner patients begin neurorehabilitation, the better their functional outcome. Brain Inj. 2013;27:1119-1123.
62. Monakhov M, Golimbet V, Abramova L, Kaleda V, Karpov V. Association study of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population. Schizophr Res. 2008;100:302-307.
63. Voisey J, Swagell CD, Hughes IP, et al. The DRD2 gene 957CT polymorphism is associated with posttraumatic stress disorder in war veterans. Depress Anxiety. 2009;26:28-33.
64. Failla MD, Burkhardt JN, Miller MA, et al. Variants of SLC6A4 in depression risk following severe TBI. Brain Inj. 2013;27;696-706.
65. Failla MD, Kumar RG, Peitzman AB, Conley YP, Ferrell RE, Wagner AK. Variation in the BDNF gene interacts with age to predict mortality in a prospective, longitudinal cohort with severe TBI [published online ahead of print July 24, 2014]. Neurorehabil Neural Repair. doi:10.1177/1545968314542617.
66. Schneider EB, Sur S, Raymont V, et al. Functional recovery after moderate/severe traumatic brain injury: A role for cognitive reserve? Neurology. 2014;82:1636-1642.
67. Wagner AK, Bayir H, Ren D, Puccio A, Zafonte RD, Kochanek PM. Relationships between cerebrospinal fluid markers of excitotoxicity, ischemia, and oxidative damage after severe TBI: The impact of gender, age, and hypothermia. J Neurotrauma. 2004;21:125-136.
68. Susman M, DiRusso SM, Sullivan T, et al. Traumatic brain injury in the elderly: increased mortality and worse functional outcome at discharge despite lower injury severity. J Trauma. 2002;53:219-223; discussion 223-224.
69. Onyszchuk G, He Y-Y, Berman NEJ, Brooks WM. Detrimental effects of aging on outcome from traumatic brain injury: A behavioral, magnetic resonance imaging, and histological study in mice. J Neurotrauma. 2008;25:153-171.
70. Kumar A, Stoica BA, Sabirzhanov B, Burns MP, Faden AI, Loane DJ. Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states. Neurobiol Aging. 2013;34:1397-1411.
71. Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry. 2007;64:327-337.
72. Wagner AK, Hatz LE, Scanlon JM, et al. Association of KIBRA rs17070145 polymorphism and episodic memory in individuals with severe TBI. Brain Inj. 2012;26(13/14):1658-1669. doi:10.3109/02699052.2012.700089.
73. Mi H, Thomas PD, Ring HZ, et al. PharmGKB summary: dopamine receptor D2. PharmacogenetGenomics. 2011;21:350-356.